Literature DB >> 18794383

Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.

Roland Wakiec1, Iwona Gabriel, Rajendra Prasad, Jeffrey M Becker, John W Payne, Slawomir Milewski.   

Abstract

The susceptibility to several oligopeptide and amino acid antifungals of a Saccharomyces cerevisiae strain carrying multiple deletions in yeast multidrug resistance genes was compared to transformants containing the CDR1, CDR2, or MDR1 genes that encode the major Candida albicans drug efflux pumps. Recombinant yeast strains overexpressing Cdr1p and Cdr2p showed enhanced susceptibilities to all tested oligopeptide antifungals. The enhanced susceptibilities of multidrug-resistant yeast strains to oligopeptide antifungals corresponded to higher rates of oligopeptide uptake. Yeast cells overexpressing Cdr1p or Cdr2p effluxed protons at higher rates than the reference cells lacking these ABC transporters. An increased plasma membrane electrochemical gradient caused by the functional overexpression of Cdr1p or Cdr2p appeared to increase cellular susceptibility to oligopeptide antifungals by stimulating their uptake via oligopeptide permeases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794383      PMCID: PMC2573099          DOI: 10.1128/AAC.01648-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death.

Authors:  A Viudes; J Pemán; E Cantón; P Ubeda; J L López-Ribot; M Gobernado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-10-31       Impact factor: 3.267

2.  Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae.

Authors:  B Regenberg; L Düring-Olsen; M C Kielland-Brandt; S Holmberg
Journal:  Curr Genet       Date:  1999-12       Impact factor: 3.886

3.  Antifungal drug resistance.

Authors:  Juergen Loeffler; David A Stevens
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

Review 4.  Multiplicity and regulation of genes encoding peptide transporters in Saccharomyces cerevisiae.

Authors:  M Hauser; V Narita; A M Donhardt; F Naider; J M Becker
Journal:  Mol Membr Biol       Date:  2001 Jan-Mar       Impact factor: 2.857

5.  Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.

Authors:  C Gyurko; U Lendenmann; E J Helmerhorst; R F Troxler; F G Oppenheim
Journal:  Antonie Van Leeuwenhoek       Date:  2001-09       Impact factor: 2.271

6.  Voriconazole and multidrug resistance in Candida albicans.

Authors:  Roland Wakieć; Rajendra Prasad; Joachim Morschhäuser; Francesco Barchiesi; Edward Borowski; Sławomir Milewski
Journal:  Mycoses       Date:  2007-03       Impact factor: 4.377

7.  Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.

Authors:  S Milewski; F Mignini; R Prasad; E Borowski
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.

Authors:  S Krishnamurthy; B L Dixit; C M Gupta; S Milewski; R Prasad
Journal:  Yeast       Date:  2002-03-15       Impact factor: 3.239

9.  Transport and hydrolysis of peptides in Saccharomyces cerevisiae.

Authors:  P Moneton; P Sarthou; F Le Goffic
Journal:  J Gen Microbiol       Date:  1986-08

Review 10.  Biogenesis and function of the yeast plasma-membrane H(+)-ATPase.

Authors:  A Ambesi; M Miranda; V V Petrov; C W Slayman
Journal:  J Exp Biol       Date:  2000-01       Impact factor: 3.312

View more
  6 in total

1.  In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.

Authors:  Jian Sun; Xia Xiao; Rui-Juan Huang; Tao Yang; Yi Chen; Xi Fang; Ting Huang; Yu-Feng Zhou; Ya-Hong Liu
Journal:  BMC Vet Res       Date:  2015-12-01       Impact factor: 2.741

2.  Fluconazole resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor.

Authors:  Garima Shahi; Mohit Kumar; Andrzej S Skwarecki; Matt Edmondson; Atanu Banerjee; Jane Usher; Neil A R Gow; Sławomir Milewski; Rajendra Prasad
Journal:  Cell Surf       Date:  2022-02-25

3.  AMPing Up the Search: A Structural and Functional Repository of Antimicrobial Peptides for Biofilm Studies, and a Case Study of Its Application to Corynebacterium striatum, an Emerging Pathogen.

Authors:  Shreeya Mhade; Stutee Panse; Gandhar Tendulkar; Rohit Awate; Yatindrapravanan Narasimhan; Snehal Kadam; Ragothaman M Yennamalli; Karishma S Kaushik
Journal:  Front Cell Infect Microbiol       Date:  2021-12-16       Impact factor: 5.293

4.  Transport Deficiency Is the Molecular Basis of Candida albicans Resistance to Antifungal Oligopeptides.

Authors:  Marta Schielmann; Piotr Szweda; Katarzyna Gucwa; Marcin Kawczyński; Maria J Milewska; Dorota Martynow; Joachim Morschhäuser; Sławomir Milewski
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

Review 5.  'Acridines' as New Horizons in Antifungal Treatment.

Authors:  Iwona Gabriel
Journal:  Molecules       Date:  2020-03-25       Impact factor: 4.411

6.  The production of L- and D-phenylalanines using engineered phenylalanine ammonia lyases from Petroselinum crispum.

Authors:  Souad Diana Tork; Emma Zsófia Aletta Nagy; Lilla Cserepes; Diana Monica Bordea; Botond Nagy; Monica Ioana Toşa; Csaba Paizs; László Csaba Bencze
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.